Servier and Neurochlore join forces to treat autism in children
Servier and Neurochlore join forces to treat autism in children
Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance